🇺🇸 FDA
Pipeline program

preoperative 0.5% ropivacaine hydrochloride preoperative

2015110901

Approved small_molecule completed

Quick answer

preoperative 0.5% ropivacaine hydrochloride preoperative for Postoperative Pain is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Postoperative Pain
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials